- Home
- NBN vs LXEO Comparison
NBN vs LXEO Comparison
Compare NBN & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NBN | LXEO |
|---|---|---|
| Founded | 1872 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 823.1M | 663.5M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | NBN | LXEO |
|---|---|---|
| Price | $100.20 | $9.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $102.00 | $18.22 |
| AVG Volume (30 Days) | 71.4K | ★ 989.3K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.04% | N/A |
| EPS Growth | ★ 38.19 | N/A |
| EPS | ★ 10.63 | N/A |
| Revenue | ★ $214,699,000.00 | N/A |
| Revenue This Year | $11.59 | N/A |
| Revenue Next Year | $11.26 | N/A |
| P/E Ratio | $9.38 | ★ N/A |
| Revenue Growth | ★ 36.17 | N/A |
| 52 Week Low | $78.17 | $1.45 |
| 52 Week High | $113.01 | $10.38 |
Technical Indicators
Market Signals| Indicator | NBN | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 71.97 | 58.16 |
| Support Level | $80.75 | $9.12 |
| Resistance Level | $93.14 | $9.71 |
| Average True Range (ATR) | 2.90 | 0.60 |
| MACD | 1.61 | 0.02 |
| Stochastic Oscillator | 96.97 | 83.43 |
Price Performance
Historical ComparisonAbout NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.